Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Hansmann

Showing results (141-150 of 259) with videos related to

Pageof 26
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2009
Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentityMargit Schraders, Sabine Oeschger, Philip M Kluin, et al.
British Journal of Haematology|October 20, 2004
Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cellsNoraidah Masir, Margaret Jones, Michela Pozzobon, et al.
The Journal of Pathology|March 25, 2017
TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphomaFriederike H Schwartz, Qian Cai, Eva Fellmann, et al.
Clinical Science (London, England : 1979)|June 25, 2014
Feasibility of global miRNA analysis from fine-needle biopsy FFPE material in patients with hepatocellular carcinoma treated with sorafenibJan Peveling-Oberhag, Claudia Döring, Sylvia Hartmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2013
Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1Tim Heinrich, Benjamin Rengstl, Alexander Muik, et al.
Leukemia|May 13, 2025
Refining histopathological growth pattern-based risk group discrimination in nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study GroupDennis A Eichenauer, Aylin Basaran, Ina Bühnen, et al.
Oncotarget|February 2, 2017
Intratumoral heterogeneity of intrahepatic cholangiocarcinomaDirk Walter, Claudia Döring, Magdalena Feldhahn, et al.
Blood|December 14, 2007
Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study GroupOlaf Determann, Eva Hoster, German Ott, et al.
Clinical and Translational Gastroenterology|May 2, 2018
Sequencing of intraductal biopsies is feasible and potentially impacts clinical management of patients with indeterminate biliary stricture and cholangiocarcinomaKatrin Bankov, Claudia Döring, Markus Schneider, et al.
Haematologica|May 23, 2024
Checkpoint inhibition enhances cell contacts between CD4<sup>+</sup> T cells and Hodgkin-Reed-Sternberg cells of classic Hodgkin lymphomaKübra Yadigaroglu, Sonja Scharf, Steffen Gretser, et al.
Pageof 26

Showing results (141-150 of 259) with videos related to

Sort By:
Pageof 26
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2009
Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentityMargit Schraders, Sabine Oeschger, Philip M Kluin, et al.
British Journal of Haematology|October 20, 2004
Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cellsNoraidah Masir, Margaret Jones, Michela Pozzobon, et al.
The Journal of Pathology|March 25, 2017
TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphomaFriederike H Schwartz, Qian Cai, Eva Fellmann, et al.
Clinical Science (London, England : 1979)|June 25, 2014
Feasibility of global miRNA analysis from fine-needle biopsy FFPE material in patients with hepatocellular carcinoma treated with sorafenibJan Peveling-Oberhag, Claudia Döring, Sylvia Hartmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2013
Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1Tim Heinrich, Benjamin Rengstl, Alexander Muik, et al.
Leukemia|May 13, 2025
Refining histopathological growth pattern-based risk group discrimination in nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study GroupDennis A Eichenauer, Aylin Basaran, Ina Bühnen, et al.
Oncotarget|February 2, 2017
Intratumoral heterogeneity of intrahepatic cholangiocarcinomaDirk Walter, Claudia Döring, Magdalena Feldhahn, et al.
Blood|December 14, 2007
Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study GroupOlaf Determann, Eva Hoster, German Ott, et al.
Clinical and Translational Gastroenterology|May 2, 2018
Sequencing of intraductal biopsies is feasible and potentially impacts clinical management of patients with indeterminate biliary stricture and cholangiocarcinomaKatrin Bankov, Claudia Döring, Markus Schneider, et al.
Haematologica|May 23, 2024
Checkpoint inhibition enhances cell contacts between CD4<sup>+</sup> T cells and Hodgkin-Reed-Sternberg cells of classic Hodgkin lymphomaKübra Yadigaroglu, Sonja Scharf, Steffen Gretser, et al.
Pageof 26